, Tracking Stock Market Picks
Enter Symbol:
(THLD) [hlAlert]

down 50.70 %

THRESHOLD PHARMACEUT (THLD) rated Buy with price target $15 by Mizuho

Posted on: Monday,  Apr 2, 2012  8:25 AM ET by Mizuho

Mizuho rated Buy THRESHOLD PHARMACEUT (NASDAQ: THLD) on 04/02/2012, when the stock price was $8.46. Since
then, THRESHOLD PHARMACEUT has lost 50.71% as of 08/03/2015's recent price of $4.17.
If you would have followed this Mizuho's recommendation on THLD, you would have lost 50.7% of your investment in 1218 days.

Threshold is focused on the discovery, development, and commercialization of small molecule therapeutics based on `Metabolic Targeting.` This approach targets abnormal glucose metabolism - a fundamental property of most solid tumors and other diseases. The company's initial focus is the treatment of cancer and benign prostatic hyperplasia, a disease characterized by overgrowth of the prostate.

as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy